Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non Operating Income: 2020-2024

Historic Non Operating Income for Terns Pharmaceuticals (TERN) over the last 5 years, with Dec 2024 value amounting to $13.3 million.

  • Terns Pharmaceuticals' Non Operating Income rose 1936.92% to $1.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.0 million, marking a year-over-year increase of 926.13%. This contributed to the annual value of $13.3 million for FY2024, which is 5.49% up from last year.
  • Terns Pharmaceuticals' Non Operating Income amounted to $13.3 million in FY2024, which was up 5.49% from $12.6 million recorded in FY2023.
  • In the past 5 years, Terns Pharmaceuticals' Non Operating Income registered a high of $13.3 million during FY2024, and its lowest value of -$2.7 million during FY2020.
  • In the last 3 years, Terns Pharmaceuticals' Non Operating Income had a median value of $12.6 million in 2023 and averaged $9.3 million.
  • Data for Terns Pharmaceuticals' Non Operating Income shows a peak YoY surged of 872.38% (in 2022) over the last 5 years.
  • Over the past 5 years, Terns Pharmaceuticals' Non Operating Income (Yearly) stood at -$2.7 million in 2020, then skyrocketed by 107.68% to $210,000 in 2021, then soared by 872.38% to $2.0 million in 2022, then skyrocketed by 516.41% to $12.6 million in 2023, then increased by 5.49% to $13.3 million in 2024.